Lumen Bioscience, a clinical-stage biopharma company, announced results from a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs.
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologics for highly prevalent diseases, has entered into a research collaboration with Novo Nordisk to evaluate Lumen's drug development and manufacturing platform in ...